International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 1330-1337
Research Article
‘‘A Clinico-Histopathological Study Of Hansen's Disease’’: A Retrospective Study In A Tertiary Care Hospital At Rajkot (Gujarat), India
 ,
 ,
 ,
 ,
Received
July 15, 2025
Accepted
Aug. 20, 2025
Published
Aug. 31, 2025
Abstract

Background: Hansen’s disease also known as Leprosy is a chronic infectious communicable disease caused mycobacterium leprae. Leprosy is known, since ancient times as "Kushtaroga", whose clinical manifestations are largely confined to the skin, peripheral nervous system, upper respiratory tract, eyes and testes. The three cardinal sign of the disease are skin lesions, skin anesthesia and enlarged peripheral nerves. This study investigated the clinico-histopathological examination of cases of Hansen’s disease at P.D.U Medical College and Hospital, Rajkot, Gujarat.

Objective: To know prevalence of leprosy, to study the histopathological features of clinically suspected cases of leprosy in skin biopsies and categorise from tuberculoid to lepromatous leprosy based on Ridley Jopling classification and examined with Fite Faraco stain to look for positivity.

Materials and Methods: The present study was carried out in the Histo-pathology laboratory, Department of Pathology, P.D.U Medical College and Hospital, Rajkot, Gujarat over a period of 11 months between August 2024 to June 2025. Skin biopsies were obtained for histopathological examination along with properly filled requisition form, including detailed clinical history, after adequate fixation and tissue processing, paraffin embedded serial sections done and sections stained with Haematoxylin & eosin stain and F. F. stain, examined under microscope.

Results: A total of 70 cases of this study, most of cases occurred in age group (21-40) years (58.56%) and showed marked male predominance with M:F ratio=3:2. Lepromatous leprosy (47.2%) was the most common histopathological type of leprosy. Maximum clinicopathological correlation seen in BL (100%), BT (75%) and MB (75%).

Conclusion: Leprosy is one of the leading causes of physical disabilities which contribute to intense social stigma resulting in discrimination of patients and their families,especially in low-economic communities. The clinical manifestations of leprosy are so diverse and can mimic a variety of unrelated diseases. Presentation may vary from an insignificant skin lesion to extensive disease. Lack of accurate diagnosis and treatment of leprosy can cause permanent damage to skin, nerves, limbs and eyes leading to deformities

Keywords
INTRODUCTION

Hansen’s disease or leprosy is a chronic infectious disease caused by Mycobacterium leprae- intracellular, obligate parasite. Untreated Leprosy affected person(human beings) is the only known source, transmitted to a susceptible person through droplets, mainly via respiratory tract. It principally affecting the cooler parts of the body, mainly skin and peripheral nerves; it also involves muscles, eyes, bones, testis and internal organs. Tuberculoid leprosy indicates a high cellular immune response (i.e., T cells and macrophage activation) and few bacilli in tissues; at the opposite pole, lepromatous leprosy indicates an absent cellular immune response to M. leprae antigens, with no macrophage activation and abundant bacilli in tissues. The spectrum of leprosy is a continuum, and patients may move in either direction according to host response and treatment. The standard delineation follows that of Ridley and Jopling, with categories defined along the spectrum by a combination of clinical, microbiological, histopathological, and immunologic indices: TT (tuberculoid), BT (borderline tuberculoid), MB (mid borderline), BL (borderline lepromatous), and LL (lepromatous). The term borderline is used to denote patterns that share some features of both tuberculoid and lepromatous leprosy.

 

Table 1: Ridley Jopling Classification of leprosy

Observation

Type of Leprosy

TT

BT

MB

BL

LL

Number of lesions

Single usually

Single or few

Several

Many

Very many

Size of lesions

Variable

Variable

Variable

Variable

Small

Surface of lesions

Very dry, sometimes scaly

Dry

Slightly shiny

Shiny

Shiny

Sensation in lesions

Absent

Moderately or markedly diminished

Slightly or moderately diminished

Slightly diminished

Not affected or minimally affected

Hair growth in lesions

Absent

Markedly diminished

Moderately diminished

Slightly diminished

Not affected

AFB in lesions

Nil

Nil or scanty

Moderate numbers

Many

Very many(plus globi)

Lepromin test

Strongly positive (+++)

Weakly positive(+ or ++)

Negative

Negative

Negative

AFB in nasal scraping or in nose blows

Nil

Nil

Nil

Usually nil

Very many(plus globi)

 

Today, access to information, diagnosis and treatment with Multi Drug Therapy(MDT) remain key elements in the strategy to eliminate the disease. The National Leprosy Eradication Programme(NLEP) was launched in 1983 with the objective of arresting the disease activity in all known cases of leprosy. Since the disease has a long incubation period it needs a longer period of surveillance.

 

OBJECTIVE

1) To find out prevalence of leprosy in our institute.

2) To study the histopathological features of clinically suspected cases of leprosy in skin biopsies and categorise from tuberculoid to lepromatous leprosy based on microscopy.

3) To study Fite Faraco stained sections of all diagnosed cases of leprosy to look for positivity.

4) To determine the nature of various leprosy lesions and to ascertain the frequency and distribution of leprosy lesions.

 

MATERIALS AND METHODS

Histopathological examination was carried out in Histopathology laboratory of Department of Pathology, PDU Government Medical College and Hospital, Rajkot between the August 2024 to June 2025 time period. Skin biopsies for the study were obtained by incisional or punch biopsy which was performed by the Dermatologist. These biopsies were kept in 10% formalin and sent for histopathological examination along with properly filled requisition form, including detailed clinical history, examination findings indicating signs and symptoms of the skin lesions and provisional clinical diagnosis. Following adequate fixation for about 8-12 hours the tissues were submitted into for routine processing, following which the paraffin embedded serial sections of 4-5 microns thickness were obtained, which were stained with Hematoxylin and Eosin for morphological assessment and Wade Fite staining for identifying the bacilli. The procedure followed for Fite Faraco Stain was Wade-Fite method for M. leprae in paraffin section.

 

 sections were observed under oil immersion using ×100 objectives. The bacillary index (BI) was assessed in exactly the same way as the one follow for smear. The entire dermis was observed to assess the logarithmic index bacilli.

 

 

 

 

 

RESULTS:

Patient Demographics:

A total of 70 cases of leprosy for histopathological evaluation with its clinical correlation and demonstration of lepra bacilli on F. F. stain were included in the study. In present study, age of the patient ranged from 0-80 years.(TABLE-2) Maximum number of cases 41(58.56%) were seen in the age group 21-40 years followed by 17(24.23%) in 41-60 years.

 

TABLE 2: Distribution of leprosy cases in different Age group:

Age range(20 years)

No. of Cases

Percentage

0-20

08

11.44%

21-40

41

58.56%

41-60

17

24.23%

61-80

04

5.71%

Total

70

100%

 

In present study consisting of 70 cases, 42(60%) were males and 28(40%)were females. Male to female ratio was 3:2 (TABLE- 3)

 

TABLE 3: Distribution of leprosy cases according to gender

Gender

No. Of Cases

Percentage

Male

42

60%

Female

28

40%

Total

70

100%

 

In present study (Table 4)the maximum number of cases 33(47.2%) cases were of lepromatous leprosy followed by 11(15.77%) cases of Borderline Tuberculoid leprosy, 10(14.3%) cases of Borderline Lepromatous , 08(11.44%) cases of Lepromatous leprosy with Erythma Nodosum Leprosum, 05(7.14%) cases of Tuberculoid leprosy, 03(4.29%) cases of Mid Borderline leprosy seen.

 

TABLE 4: Distribution of various types of leprosy by histopathological examination

Type

No. Of Cases

Percentage

TT

05

7.14%

BT

11

15.77%

MB

03

4.29%

BL

10

14.3%

LL

33

47.2%

LL WITH ENL

08

11.44%

Total

70

100%

 

(TT- Tuberculoid leprosy, BT- Borderline Tuberculoid leprosy, MB- Mid Borderline leprosy, BL- Borderline Lepromatous leprosy, LL- Lepromatous Leprosy, LL with ENL- Lepromatous Leprosy with Erythema Nodosum Leprosum)

 

TABLE 5:Distribution of clinical features in various types of leprosy

Cytological diagnosis

No. Of Cases

Percentage

Hypopigmented lesions

22

31.44%

Erythematous lesions

22

31.44%

Combined lesions(macule and papule)

21

30%

Anesthesia (loss of sensation)

07

10%

Nerve thickening

11

15.77%

Nodules

10

14.23%

Tingling and numbness

36

51.44%

 

Out of 70 cases of skin biopsies it can be observed(Table 5) that Tingling and numbness seen in 36 cases(51.44%)which was the most common clinical feature, Hypopigmented lesions and Erythematous lesions seen in 22 cases(31.44%)were 2nd most common feature observed followed by Nerve thickening seen in 11 cases(15.77%), Nodules seen in 10 cases(14.23%) and anesthesia(loss of sensation) seen in 07 cases(10%).

 

TABLE 6: Correlation of clinical and histopathological classification in leprosy cases

Clinical type

Clinically diagnosed cases

TT

BT

MB

BL

LL

LL WITH ENL

Percentage

TT

07

05

02

00

00

00

00

71.42%

BT

08

00

06

00

01

00

01

75%

MB

04

00

01

03

00

00

00

75%

BL

03

00

00

00

03

00

00

100%

LL

43

00

02

00

03

33

05

76.74%

LL WITH ENL

05

00

00

00

03

00

02

40%

Total

70

05

11

03

10

33

08

72.32%

 

(TT- Tuberculoid leprosy, BT- Borderline Tuberculoid leprosy, MB- Mid Borderline leprosy, BL- Borderline Lepromatous leprosy, LL- Lepromatous Leprosy, LL with ENL- Lepromatous Leprosy with Erythema Nodosum Leprosum)

 

From Table 6 it can be observed that the overall concordance between clinical and histopathological classification was   72.32%. Maximum concordance was seen in Borderline lepromatous leprosy which was 100% followed by 75% in BT, 75% MB, 76.74% in LL, 71.42% in TT.

 

TABLE 7: Percentage distribution of F F Stain positivity among various histologic types of leprosy

Type of leprosy

Total no of cases

No of positive cases

Percentage

TT

05

04

80%

BT

11

06

54.54%

MB

03

02

66.66%

BL

10

09

87.5%

LL

33

33

100%

LL WITH ENL

08

08

100%

Total

70

62

88.57%

 

(TT- Tuberculoid leprosy, BT- Borderline Tuberculoid leprosy, MB- Mid Borderline leprosy, BL- Borderline Lepromatous leprosy, LL- Lepromatous Leprosy, LL with ENL- Lepromatous Leprosy with Erythema Nodosum Leprosum)

 

From above table 7 it can be said that out of 70 cases which were diagnosed by Histopathological examination into different form of leprosy , 62 cases (88.57%)were F. F. Positive. Out of these positive cases, maximum cases of LL were found. Low positivity was seen in BT and MB.

Bacillary index was highest in HL, LL and BL having grade 5+, 6+ while it was lower in other types of leprosy ranging from 1+ to 4+

 

 

 

 

 

 

 

 

 

 

 

DISCUSSION

The present study demonstrated the clinico-histopathological examination of total 70 cases of leprosy of August 2024 to July 2025(11 months) was carried out in the Department of Pathology, P.D.U. Government Medical College & Hospital, Rajkot. Accurate diagnosis is of fundamental importance to all aspects of leprosy epidemiology, management and prevention of disability. Under diagnosis will lead to continued transmission of disease and much needless sufferings. The attitude of society, methods of case detection, type of personnel carrying out survey, method and frequency of examination, the criteria adopted for diagnosis, type of classification of disease, are some variables that affect the description of the condition. Histopathological examination continues to be an important tool in accurate diagnosis and classification of leprosy and still remains the gold standard.

 

Table 8: Comparison of gender distribution in leprosy cases with various study

 

Present study

Tiwari et al

(2015)

Mathur et al

(2011)

Nadia et al

(2015)

No of cases

70

53

156

118

MALE

42

31

84

76

FEMALE

28

22

72

42

 

From above table-8 it can be observed that male preponderance observed in present study(60%) is comparable to all other studies which reported M:F ratio from 1.5, 1.4, 1.1, 1.8.

 

Table 9: Comparison of spectrum of leprosy of present study with various study

TYPE OF LEPROSY

Present study

Tiwari et al(2015)

Mathur et al(2011)

Nadia et al(2015)

TT

05

04

43

17

BT

11

22

39

41

MB

03

03

07

19

BL

10

22

30

12

LL

32

02

21

29

LL WITH ENL

08

00

00

00

NO EVIDENCE OF LEPROSY

00

00

16

00

TOTAL

70

53

156

118

 

(TT- Tuberculoid leprosy, BT- Borderline Tuberculoid leprosy, MB- Mid Borderline leprosy, BL- Borderline Lepromatous leprosy, LL- Lepromatous Leprosy, LL with ENL- Lepromatous Leprosy with Erythema Nodosum Leprosum)

From above table-9 it is observed that In present study most common type of leprosy was the lepromatous leprosy , 33 cases(47.2%) followed by borderline tuberculoid leprosy is comparable to all other studies which suggest that no. Of infective cases (LL) are more common in Gujarat state as in present study.

Table 10: Comprison of clinicopathological correlation

Studies

TT

BT

MB

BL

LL

HL

Present study

71.42%

75%

75%

100%

72.5%

00%

Sindhushree et al21

25%

37.89%

8.30%

12.50%

33.30%

57.14%

Kalla et al22

76.70%

44.20%

37%

43.70%

75.60%

-

 

(TT- Tuberculoid leprosy, BT- Borderline Tuberculoid leprosy, MB- Mid Borderline leprosy, BL- Borderline Lepromatous leprosy, LL- Lepromatous Leprosy, HL- Histoid Leprosy)

 

Different studies showed variable clinicopathological correlation. In present study, maximum clinicopathological correlation seen in cases of Borderline Lepromatous leprosy (100%) while in Sindhushree et al study maximum correlation seen in Histoid leprosy (57.14%) and in Kalla et al maximum clinicopathological seen in cases of TT (76.70%).21,22

Out of 70 patient, which were diagnosed by Histopathological examination into different forms of leprosy, Modified fite faraco stain positivity was in 88.57% was somewhat higher to the study of Deepa sowkur Anandarma aligra and Surekha B Hippargi 2 in 2016. It may be due to more cases of LL in present study.

 

CONCLUSION

Leprosy is one of the leading causes of physical disabilities which contribute to intense social stigma resulting in discrimination of patients and their families,especially in low-economic communities.The clinical manifestations of leprosy are so diverse and can mimic a variety of unrelated diseases. Presentation may vary from an insignificant skin lesion to extensive disease. Lack of accurate diagnosis and treatment of leprosy can cause permanent damage to skin, nerves, limbs and eyes leading to deformities.

 

REFERENCES

  1. Hastings RC, Gillis TP, Krahenbuhl JL, Franzblau SG. Leprosy ClinMicrobiol Rev 1988; 1: 330-348.
  2. Announcement: India achieves national elimination of leprosy. Indian J Lepr 2006; 78: 101.
  1. Lowe J. Comments on the history of Leprosy. Lepr Rev 1947, 18: p. 54-63.
  2. NLEP Progress Report for the year 2017-18, Central Leprosy Division Directorate General of Health Services NirmanBhawan, New Delhi.
  3. Shantaram B, Yawalkar SJ. Leprosy Differential Diagnosis. In: Valia RG, Valia AR editors, Textbook and Atlas of Dermatology. Bombay, Bhalani Publishing House; 1994. p.1385-91.
  4. Manandhar U, Adhikari RC, Sayami G. Clinico-histopathological correlation of skin biopsies in leprosy. J Pathol Nepal 2013;3:452-8.
  5. Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull 2006;77-78:103-21.
  6. Parkash O. Classification of leprosy into multibacillary and paucibacillary groups: An analysis. FEMS Immunol Med Microbiol 2009;55:1-5.
  7. Shivamurthy V, Gurubasavaraj H, Sastry SP, Kumar P. Histomorphological study of leprosy. Afr J Med Health Sci 2013;12:68-7
  8. Pardillo FE, Fajardo TT, Abalos RM, Scollard D. Gelber RH Methods for the classification of leprosy for treatment purposes. Clin Infect Dis 2007:44:1096-9
  9. Ridley DS & Jopling WH. A Classification of leprosy for research purposes. Lepr Rev 1962; 33: 119-28
  10. Ganapathy R, Revankar CR. Leprosy. Controle. In: Valia RG, Valia AR, editors. Textbook and Atlas of Dermatology. Bombay: Bhalani Publishing House; 1994. p. 1427-37.
  11. Culling CF, Allison RT. Barr WT. Micro organisms. In: Cellular Pathology Technique. 4th ed. London: Butterworth and Company Ltd.; 1985. p. 331-46.
  12. Ridley DS. A logarithmic index of bacilli in biopsies. 2. Evaluation. Int J Lepr Other Mycobact Dis 1967;35:187-93
  13. McDougall A.C. Histopathological examination of skin biopsies. International J. of Lep. 55:88-89, 1987
  14. CFA Culling, text book of histopathological techniques, 3rd edition, 211-220,1975.
  15. Theory and practice of histopathological techniques. 4 edition. Hong Kong; Churchill livingstone ; 1996. P.99-112,306-307.
  16. Dharmendra vol. 1.
  17. Dharmendra: Notes in leprosy, Ministry of health. Publication. Government of india 2nd edition. 1967.
  18. E. H. Jopling, Handbook of Leprosy. 3rd edition .1985.
Recommended Articles
Research Article Open Access
A Foe For Lung Is A Friend For Heart: Intrapericardial Bleomycin For Malignant Pericardial Effusion – A Case Series
2025, Volume-6, Issue-4 : 1410-1416
Research Article Open Access
A study of epidemiology of pityriasis rosea and therapeutic effect of narrow band ultra violet B phototheraphy on its course
2025, Volume-6, Issue-4 : 1381-1395
Research Article Open Access
CT-Derived Perinephric Fat Stranding As A Predictor Of Infectious Complications In Patients With Obstructive Urolithiasis
2025, Volume-6, Issue-4 : 1322-1329
Research Article Open Access
Clinical Profile and Spectrum of Respiratory Disorders in Patients with Chronic Kidney Disease
2025, Volume-6, Issue-4 : 1296-1300
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue-4
Citations
11 Views
6 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved